MGC Diagnostics Corporation

10/01/2026 | News release | Distributed by Public on 10/01/2026 07:43

MGC Diagnostics Expands Direct Commercial Operations Across Canada

By MGC Diagnostics

Decades of cardiorespiratory diagnostics expertise, now delivered directly to Canadian healthcare providers

October 1, 2026 - St. Paul, MN

Canadian pulmonary function labs, hospitals and clinics now work directly with MGC Diagnostics, the team that designs, builds and supports their diagnostic systems.

For decades, Canadian clinicians have relied on MGC technology for accurate, reliable results. A direct relationship brings them closer to the source. Customers now have a direct line to MGC's sales specialists, product experts and technical support team. That means faster answers, deeper product knowledge and a partner fully accountable for their success.

"Canadian clinicians have trusted MGC systems in their labs for decades," said Corey Eckhoff, Senior Vice President, Sales and Marketing. "Working with them directly means we hear their needs firsthand and can act on them faster, whether that's supporting a system in the field or helping a lab plan its next upgrade. We're investing in Canada for the long term."

MGC serves pulmonology clinics, hospitals, cardiac rehabilitation centres and research institutions across Canada. Its portfolio includes pulmonary function testing, cardiopulmonary exercise testing, Ascentâ„¢ software and diagnostic supplies. Dedicated East and West territory representatives support customers coast to coast.

Ready to connect? Contact your Canadian sales representative for more information or to request a demo.

MGC Diagnostics Corporation published this content on October 01, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 01, 2026 at 13:43 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]